JERMAINE FLANAGAN: Open Payments
NPI 1710113196 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,460 in 48 payments from 12 companies in 2025. Trend: 2023 $138 · 2024 $14 · 2025 $1,460
Food & beverage: $1,460
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 17 | $499 |
| Novo Nordisk Inc | 6 | $290 |
| Astellas Pharma US Inc | 4 | $181 |
| Dexcom, Inc. | 6 | $170 |
| Axsome Therapeutics, Inc. | 1 | $112 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| Exact Sciences Corporation | 2 | $29 |
| Viatris Specialty LLC | 1 | $20 |
| Amgen Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 2 | $16 |
Products named: RELTONE 200 MG, Veozah, DEXCOM G7 GSS (161), Ozempic, Symbravo, BREZTRI, FARXIGA, Cologuard Collection Kit.
Industry payments across NV — which companies pay providers there.
